Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Fallopian Tube Cancer|Endometrial Cancer|Solid Tumors
Interventions: DRUG: STM 434|DRUG: Liposomal doxorubicin
Sponsor: Santa Maria Biotherapeutics